Diabetologia

Papers
(The H4-Index of Diabetologia is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study571
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)275
Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study239
Hypoxia and hypoxia-inducible factors in diabetes and its complications168
New closed-loop insulin systems141
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses139
Exercise and metabolic health: beyond skeletal muscle132
An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study129
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)127
Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort study118
Interpreting global trends in type 2 diabetes complications and mortality113
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study112
Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)111
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies110
Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature108
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial102
Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)99
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Stud99
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis92
Incidence of newly diagnosed diabetes after Covid-1991
Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia91
Defining the underlying defect in insulin action in type 2 diabetes89
The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis87
The clinical consequences of heterogeneity within and between different diabetes types86
Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults85
Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents81
Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission77
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study76
Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?72
Chrono-nutrition for the prevention and treatment of obesity and type 2 diabetes: from mice to men71
Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants71
Hyperglycaemia on admission to hospital and COVID-1967
Current and future therapies for type 1 diabetes65
The promise of stem cell-derived islet replacement therapy62
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease62
Organisation of the human pancreas in health and in diabetes62
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis61
A global perspective on the issue of access to insulin60
The consequences of hypoglycaemia60
Metabolic and functional specialisations of the pancreatic beta cell: gene disallowance, mitochondrial metabolism and intercellular connectivity59
Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study59
Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature57
Intestinal microbial metabolites in human metabolism and type 2 diabetes56
Alpha cell regulation of beta cell function55
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment53
Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes53
Sex differences in type 2 diabetes52
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes52
Pancreatic beta cell autophagy is impaired in type 1 diabetes52
Paracrine regulation of insulin secretion50
0.048062086105347